Evidence map›Paper›PMID 40561381›Full record

ArticleNeurology2025

Cross-Sectional and Longitudinal Associations of Neighborhood Disadvantage With Fluid Biomarkers of Neuroinflammation and Neurodegeneration.

Marissa A Gogniat, Omair A Khan, Brina Ratangee, Corey J Bolton, Panpan Zhang, Dandan Liu, Kimberly R Pechman, Alexis Yates, Leslie S Gaynor, James Eaton and 6 more

Erratum issuedAbstract read
In one paragraph

Article in Neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Marissa A GogniatVanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0001-8331-693X
Omair A KhanVanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN.
Brina RatangeeVanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN.
Corey J BoltonVanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-1715-5370
Panpan ZhangVanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN.
Dandan LiuVanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN.
Kimberly R PechmanVanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN.
Alexis YatesVanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN.
Leslie S GaynorVanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0003-1121-4365
James EatonVanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0003-0010-921X
Amalia PetersonVanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN.
Katherine A GiffordVanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN.
Timothy J HohmanVanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-3377-7014
Kaj BlennowDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgreska Academy, Gothenburg, Sweden.ORCID 0000-0002-1890-4193
Henrik ZetterbergDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgreska Academy, Gothenburg, Sweden.ORCID 0000-0003-3930-4354
Angela L JeffersonVanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-8245-0587

Funding

Vanderbilt Memory & Aging ProjectR01AG034962 · NIA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI JEFFERSON, ANGELA L. · 2011 to 2025
$24.1M
NIA NIH HHS R01 AG034962
6 · The paper itself

Abstract

BACKGROUND AND

objectivesLiving in a socioeconomically disadvantaged neighborhood has an adverse impact on health outcomes, including increased risk of Alzheimer disease (AD). The biological mechanisms underlying this risk are poorly understood. We sought to examine how neighborhood disadvantage relates to core AD pathology, neurodegeneration, and inflammatory biomarkers in community-dwelling older adults cross-sectionally and over time.

methodsParticipants included older adults from the Vanderbilt Memory and Aging Project who underwent fasting blood and CSF acquisition serially over a 9-year follow-up period (mean follow-up = 6.4 years [blood] and 4.0 years [CSF]). Area Deprivation Index (ADI), representing neighborhood disadvantage, was quantified at baseline using 17 components (e.g., housing, income, education, and household characteristics), with higher values indicating greater disadvantage. Ordinary least-squares regressions cross-sectionally related ADI to plasma and CSF inflammatory biomarkers adjusting for age, sex, race/ethnicity, education, modified Framingham Stroke Risk Profile score,

resultsParticipants (n = 334; 73 ± 8 years old, 59% male, 86% White, non-Hispanic) on average were from relatively less disadvantaged neighborhoods (ADI national decile = 33 ± 25, range = 1-98). Greater neighborhood disadvantage at study entry was cross-sectionally associated with elevated CSF YKL-40 (β = 0.7, DISCUSSION: Greater neighborhood disadvantage was associated with elevated inflammatory and AD CSF biomarkers cross-sectionally and longitudinal increases in a nonspecific inflammatory blood biomarker. Findings suggest that neighborhood disadvantage confers risk of systemic inflammation and AD pathology, providing a possible sociobiological mechanism underlying health disparities in aging adults; however, results were limited by use of ADI at study entry.

Indexed as

Alzheimer DiseaseNeighborhood CharacteristicsNeuroinflammatory DiseasesAgedAged, 80 and overAmyloid beta-PeptidesBiomarkersChitinase-3-Like Protein 1Cross-Sectional StudiesFemaleHumansLongitudinal StudiesMalePeptide Fragmentstau ProteinsAmyloid beta-PeptidesBiomarkersCHI3L1 protein, humanChitinase-3-Like Protein 1Peptide Fragmentstau Proteins

Identifiers

PMID40561381
PMCPMC12203597

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.